Jefferies analyst Tycho Peterson upgraded GeneDx (WGS) to Buy from Hold with an unchanged price target of $80. After spending time with management, the firm is confident in 30% volume growth for 2025 for GeneDx. It sees a second half of 2025 ramp from NICU and new indications, while further cost reductions offers room for margin expansion. Jefferies finds the stock’s valuation “compelling” after the recent selloff.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGS:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue